Advertisement
Medical
Subscribe to Medical
View Sample

FREE Email Newsletter

Daily news and top headlines for manufacturing professionals

FDA, USDA, Cornell University announce alliance for produce safety

November 4, 2010 6:46 am | by U.S. Food & Drug Administration | News | Comments

A public-private organization will provide produce growers and packagers with fundamental, on-farm food safety knowledge, in advance of a proposed produce safety regulation, the U.S. Food and Drug Administration, the U.S. Department of Agriculture’s Agricultural Marketing Service...

FDA, University of Rochester announce partnership for new drug products

November 1, 2010 11:47 am | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration today announced a partnership agreement with the University of Rochester to form the Analgesic Clinical Trial Innovations, Opportunities, and Networks (ACTION) Initiative.

McKesson To Acquire U.S. Oncology In $2.16B Deal

November 1, 2010 5:16 am | News | Comments

Medical company said Monday it will acquire U.S. Oncology in an all-cash deal it valued at $2.16 billion.

Advertisement

FDA Approves Teflaro for Bacterial Infections

October 29, 2010 12:45 pm | by U.S. Food & Drug Administration | News | Comments

CABP, MRSA

Baxter Selling Injectables Unit For $112M

October 29, 2010 5:44 am | News | Comments

Medical products manufacturer said Friday it is selling its U.S. generic injectables business to Hikma Pharmaceuticals PLC for about $112 million.

FDA approves Latuda to treat schizophrenia in adults

October 28, 2010 12:46 pm | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia.

FDA approves additional medical indication for Sprycel

October 28, 2010 8:46 am | by U.S. Food & Drug Administration | News | Comments

Sprycel, CML

Stryker Corp. To Buy Boston Scientific Division

October 28, 2010 5:11 am | News | Comments

Company says it will pay up to $1.5 billion to buy the neurovascular division of fellow medical device maker Boston Scientific.

Advertisement

U.S. Marshals seize FDA-regulated food stored at rodent-infested warehouse in Georgia

October 27, 2010 11:47 am | by U.S. Food & Drug Administration | News | Comments

U.S. Marshals, acting under a court order sought by the U.S. Food and Drug Administration, today seized an estimated $700,000 worth of rice and other packaged food products from a rodent-infested warehouse in East Point, Ga. The FDA-regulated food products were stored in a warehouse...

Federal government takes action against Tennessee food distributor

October 27, 2010 7:46 am | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration today announced that Peng Bandith, owner of the Lao Trading Company of Nashville has signed a consent decree that permanently prohibits Lao Trading Co. from distributing food held under insanitary conditions in interstate commerce. (DSK)

Hyland’s Teething Tablets may pose a risk to children

October 23, 2010 6:46 pm | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration today is warning consumers that Hyland’s Teething Tablets may pose a risk to children. The FDA recommends that consumers not use this product and dispose of any in their possession. The manufacturer is issuing a recall of this product.

FDA Heightens Focus on Retail Food Safety

October 22, 2010 9:46 am | by U.S. Food & Drug Administration | News | Comments

The Food and Drug Administration called today for stepped up efforts to improve food safety practices in retail food establishments, specifically pointing to the need for the presence of certified food safety managers to oversee safety practices. FDA pledged to work closely with state and...

FDA: Include warnings on risk for class of prostate cancer drugs

October 20, 2010 11:46 am | by U.S. Food & Drug Administration | News | Comments

GnRH agonists, prostate, cancer

Advertisement

St. Jude Medical 3Q profit grows 25 percent

October 20, 2010 7:35 am | by The Associated Press | News | Comments

St. Jude Medical Inc. on Wednesday reported a 25 percent jump in third-quarter profit as it booked fewer charges and saw stronger sales of medical devices. The company also raised its outlook for the fourth quarter and full year above Wall Street expectations.St. Jude said its net income grew...

FDA approves Pradaxa to prevent stroke in people with atrial fibrillation

October 19, 2010 2:45 pm | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration today approved Pradaxa capsules (dabigatran etexilate) for the prevention of stroke and blood clots in patients with abnormal heart rhythm (atrial fibrillation).

Boston Sci posts 3Q profit despite sales drop

October 19, 2010 1:36 pm | by MATTHEW PERRONE - AP Business Writer - Associated Press | News | Comments

Shares of medical device maker Boston Scientific jumped Tuesday after the company said it swung to a profit in the third quarter thanks to lower restructuring costs.The higher earnings came despite a decline in sales of the company's top-selling devices, heart-pacing devices and artery-opening...

FDA Provides Update on LASIK Quality of Life Collaboration Project Status

October 19, 2010 7:46 am | by U.S. Food & Drug Administration | News | Comments

LASIK, eye, laser

Idex Corp. says 3Q profit surges 30 percent

October 18, 2010 3:35 pm | by The Associated Press | News | Comments

Idex Corp., which manufactures the Jaws of Life rescue equipment and other products, said Monday its third-quarter profit surged 30 percent on higher sales.For the month that ended Sept. 30, the manufacturer reported net income of $38.6 million, or 47 cents a share. That compared with net...

FDA approves Botox to treat chronic migraine

October 15, 2010 1:45 pm | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month.

FDA participates in ‘International Internet Week of Action’

October 14, 2010 10:46 am | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration and other regulatory and international partners have completed the International Internet Week of Action (IIWA), a coordinated, cooperative effort to curb online sales and distribution of counterfeit and illicit medical products. IIWA took place...

Qualcomm Unveils RaptorQ Product for Enhanced Digital Content Delivery

October 14, 2010 8:45 am | by Qualcomm | News | Comments

SAN DIEGO – October 14, 2010 – Qualcomm Incorporated (NASDAQ: QCOM) today announced the commercial license availability of RaptorQ, a flexible and powerful software technology for forward-error correction (FEC). Based on technology acquired from Digital Fountain, Qualcomm’s RaptorQ...

FDA issues warnings to marketers of unapproved ‘chelation’ products

October 14, 2010 8:45 am | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration today warned eight companies that their over-the-counter (OTC) chelation products are unapproved drugs and devices and that it is a violation of federal law to make unproven claims about these products. There are no FDA-approved OTC chelation products.

FDA: Possible increased risk of thigh bone fracture with bisphosphonates

October 13, 2010 9:45 am | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration today warned patients and health care providers about the possible risk of atypical thigh bone (femoral) fracture in patients treated with bisphosphonates, a class of drugs used to prevent and treat osteoporosis. A labeling change and Medication Guide...

FDA schedules third orphan drug workshop for Nov. 4-5, 2010

October 13, 2010 6:46 am | by U.S. Food & Drug Administration | News | Comments

The U.S. Food and Drug Administration has scheduled the third in a series of workshops on orphan drug designation for academics, biotechnology companies, and those unfamiliar with the process for Nov. 3-4, 2010, in Lansdowne, Va.

Qualcomm Innovation Center, Inc. Acquires iSkoot Technologies Inc., a Leader in Mobilizing Internet Services on the Handsets Most People Use Today

October 13, 2010 6:46 am | by Qualcomm | News | Comments

SAN DIEGO – October 13, 2010 – Qualcomm Innovation Center, Inc. (QuIC), a wholly owned subsidiary of Qualcomm Incorporated (NASDAQ: QCOM), today announced it has acquired iSkoot Technologies Inc., a newly-formed corporation that has recently received substantially all of the assets of...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading